Concepedia

Patient-reported outcomes with adjuvant exemestane versus tamoxifen in premenopausal women with early breast cancer undergoing ovarian suppression (TEXT and SOFT): a combined analysis of two phase 3 randomised trials

Jürg Bernhard, Weixiu Luo, Karin Ribi, Marco Colleoni, Harold J. Burstein, Carlo Tondini, Graziella Pinotti, Simon Spazzapan, Thomas Ruhstaller, Fabio Puglisi,

The Lancet Oncology · 2015 · 179 citations · 28 references

DOIFull text

Open access

Concepts

References

28

The CES-D Scale

Lenore Sawyer Radloff · Applied Psychological Measurement · 1977 · 53.3K citations · Full text

, , +17

Exemestane for Breast-Cancer Prevention in Postmenopausal Women

Paul E. Goss, James N. Ingle, José E. Alés‐Martínez et al. · New England Journal of Medicine · 2011 · 961 citations · Full text

, , +17

Adjuvant Exemestane with Ovarian Suppression in Premenopausal Breast Cancer

Olivia Pagani, Meredith M. Regan, Barbara Walley et al. · New England Journal of Medicine · 2014 · 747 citations · Full text

, , +17

On the Receiving End

Jean M. Bartunek, Denise M. Rousseau, Jenny W. Rudolph et al. · The Journal of Applied Behavioral Science · 2006 · 532 citations

, , +17

Health-Related Quality of Life and Tamoxifen in Breast Cancer Prevention: A Report From the National Surgical Adjuvant Breast and Bowel Project P-1 Study

Richard Day, Joseph P. Costantino, Walter M. Cronin et al. · Journal of Clinical Oncology · 1999 · 444 citations

, , +17